Abstract
An older cancer patient who is frail has reduced tolerance to treatment such as chemotherapy and surgery and is at increased risk of toxicity and complications. The term frailty is defined as an increased vulnerability to stressors due to a multisystem reduction in reserve capacity. Frailty is linked to higher chronological age and comorbidities but is considered a distinct concept. By identifying frailty in a cancer patient, the treating physician gets a more precise estimation of individual vulnerability compared to looking at chronological age alone. Recognizing frailty has consequences for treatment decisions in the oncology setting because frailty summarizes health status. A patient who is frail has a limited life expectancy compared to a fit patient with the same chronological age. When interpreting clinical trials in older cancer patients, reporting of patient frailty in addition to age is necessary because it is relevant for evaluating generalizability to clinical practice. Unfortunately, frail patients are often excluded from clinical trials.
This is a preview of subscription content, log in via an institution.
Abbreviations
- ADL:
-
Activities of daily living
- CI:
-
Confidence interval
- G8:
-
Geriatric-8
- GA:
-
Geriatric assessment
- VES-13:
-
Vulnerable Elders Survey-13
References
Akishita M, Ishii S, Kojima T, et al. Priorities of health care outcomes for the elderly. J Am Med Dir Assoc. 2013;14:479–84.
Baitar A, Van Fraeyenhove F, Vandebroek A, et al. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy. J Geriatr Oncol. 2014;5:179–84.
Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224–37.
Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2015;44:148–52.
Covinsky KE, Pierluissi E, Johnston CB. Hospitalization-associated disability: “She was probably able to ambulate, but I’m not sure”. JAMA. 2011;306:1782–93.
Denkinger MD, Hasch M, Gerstmayer A, et al. Predicting fatigue in older breast cancer patients receiving radiotherapy. A head-to-head comparison of established assessments. Z Gerontol Geriatr. 2015;48:128–34.
Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012;118:3377–86.
Feng MA, McMillan DT, Crowell K, et al. Geriatric assessment in surgical oncology: a systematic review. J Surg Res. 2015;193:265–72.
Fong TG, Davis D, Growdon ME, et al. The interface between delirium and dementia in elderly adults. Lancet Neurol. 2015;14:823–32.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Med Sci. 2001;56:M146–56.
Fried TR, Bradley EH, Towle VR, et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346:1061–6.
Hamaker ME, Jonker JM, de Rooij SE, et al. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol. 2012;13:e437–44.
Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26:1091–101.
Hshieh TT, Yue J, Oh E, et al. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015;175: 512–20.
Hubbard RE, Woodhouse KW. Frailty, inflammation and the elderly. Biogerontology. 2010;11:635–41.
Huisingh-Scheetz M, Walston J. How should older adults with cancer be evaluated for frailty? J Geriatr Oncol. 2017;8:8–15.
Huisman MG, Kok M, de Bock GH, et al. Delivering tailored surgery to older cancer patients: preoperative geriatric assessment domains and screening tools – a systematic review of systematic reviews. Eur J Surg Oncol. 2017;43:1–14.
Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29:3457–65.
Inouye SK, Studenski S, Tinetti ME, et al. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55: 780–91.
Jones TS, Dunn CL, Wu DS, et al. Relationship between asking an older adult about falls and surgical outcomes. JAMA Surg. 2013;148:1132–8.
Kristjansson SR, Nesbakken A, Jordhoy MS, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol. 2010;76:208–17.
Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28:2046–50.
Manal B, Suzana S, Singh DK. Nutrition and frailty: a review of clinical intervention studies. J Frailty Aging. 2015;4:100–6.
Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323–36.
Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14:392–7.
Odden MC, Peralta CA, Haan MN, et al. Rethinking the association of high blood pressure with mortality in elderly adults. Arch Intern Med. 2012;172:1162–8.
Ommundsen N, Wyller TB, Nesbakken A, et al. Frailty is an independent predictor of survival in older patients with colorectal cancer. Oncologist. 2014;19:1268–75.
Pamoukdjian F, Levy V, Sebbane G, et al. Slow gait speed is an independent predictor of early death in older cancer outpatients: results from a prospective cohort study. J Nutr Health Aging. 2017;21:202–6.
Petit-Moneger A, Rainfray M, Soubeyran P, et al. Detection of frailty in elderly cancer patients: improvement of the G8 screening test. J Geriatr Oncol. 2016;7:99–107.
Ramsdale E, Polite B, Hemmerich J, et al. The Vulnerable Elders Survey-13 predicts mortality in older adults with later-stage colorectal cancer receiving chemotherapy: a prospective pilot study. J Am Geriatr Soc. 2013;61:2043–4.
Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PLoS One. 2014;9:e115060.
Tsoi KK, Chan JY, Hirai HW, et al. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015;175:1450–8.
Winograd CH, Gerety MB, Chung M, et al. Screening for frailty: criteria and predictors of outcomes. J Am Geriatr Soc. 1991;39:778–84.
Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc. 2012;60:1478–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Rostoft, S. (2019). Frailty in Cancer Patients. In: Extermann, M. (eds) Geriatric Oncology . Springer, Cham. https://doi.org/10.1007/978-3-319-44870-1_48-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-44870-1_48-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-44870-1
Online ISBN: 978-3-319-44870-1
eBook Packages: Springer Reference MedicineReference Module Medicine